Katherine E. Stagliano

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis

Ronggai Sun, Yasir A. W. Skeiky, Angelo Izzo et al. · Vaccine · 2009 · 158 citations · Full text

Life Sciences, Immunology, Microbiology +11

Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression

Mariano J. Scian, Katherine E. Stagliano, Michelle A. E. Anderson et al. · Molecular and Cellular Biology · 2005 · 149 citations · Full text

Medicine, Molecular Biology, Oncology +16

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

Stephanie K. Watkins, Ziqiang Zhu, Elena Riboldi et al. · Journal of Clinical Investigation · 2011 · 131 citations · Full text

Medicine, Immunology, Oncology +17

Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes

Mariano J. Scian, Katherine E. Stagliano, Debabrita Deb et al. · Oncogene · 2004 · 118 citations

Medicine, Genetics, Oncology +14

Modulation of Gene Expression by Tumor-Derived p53 Mutants

Mariano J. Scian, Katherine E. Stagliano, Michelle A. Ellis et al. · Cancer Research · 2004 · 115 citations

Life Sciences, Genetics, Oncology +15